Hair Regeneration in Androgenetic Alopecia using Secretome of Adipose-derived Stem Cells (ADSC) and Minoxidil: A Comparative Study of Three Groups

Author:

Legiawati Lili1ORCID,Sitohang Irma Bernadette S.1,Yusharyahya Shannaz Nadia1,Sirait Sondang P.1,Novianto Endi1,Liem Isabella Kurnia2,Kurniawati Trie2,Putri Ines Soepinarko2,Rahmadika Faizal Dzaky3,Hakiki Nadhira Permata1,Lauren Brigitta Cindy1

Affiliation:

1. Universitas Indonesia Fakultas Kedokteran

2. RSUPN Dr Cipto Mangunkusumo: Rumah Sakit Dr Cipto Mangunkusumo

3. Universitas Indonesia

Abstract

Abstract Introduction: Androgenetic alopecia (AGA) is one of the most common cause of hair loss disorder, characterized by the shortening duration of anagen phase, increased telogen phase, and miniaturization of hair follicles, eventually leading to their regression. This disorder tends to progress into partial or even complete baldness. Several therapeutic options are now available for AGA, including conventional medications such as finasteride, dutasteride, and minoxidil. However, side effects of these medications are also commonly reported. The use of adipose derived stem cells (ADSCs) and their secreted bioactive molecules, “secretome” has gained attention which could produce many effects for hair growth promotion and has been proven in clinical trials. However, there is still insufficient evidence regarding the comparison of effectiveness of secretome with treatments like minoxidil. Objective: This study aims to compare the effectiveness and safety of secretome from ADSCs with minoxidil in AGA cases, to provide future reference in the application of cell-based therapy in AGA cases. Method: 60 subjects were divided into three treatment groups (minoxidil only, secretome only, and combination of both) and were given intervention on week 0, 4, and 8. All subjects were evaluated by physical examination, photography, trichoscopy, and trichoscan until week 12. Results: All groups showed a statistically significant improvement (p <0.05) on hair growth parameters from week 4, with the best improvement observed on week 12. There were a significant difference between groups on some of the delta hair growth parameters (p <0.05), observed between secretome and combination groups. The combination group had the best improvement substantially on hair growth parameters. Side effects are minimum and only reported by the subjects in minoxidil group. Conclusion: All of the interventions give a significant improvement on hair growth with the best improvement observed after 12 weeks. However, the best improvement substantially were observed in combination group.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Androgens and alopecia;Kaufman KD;Mol Cell Endocrinol,2002

2. l Hair disorder in dr. Cipto Mangunkusumo cosmetic dermatology and venereology outpatient clinic of Jakarta, Indonesia: A socio-demographic and clinical evaluation;Legiawati L;Dermatol Rep,2022

3. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.Cosmet Dermatol. 2021;20(12):3759–3781. doi: 10.1111/jocd. 14537. Epub 2021 Nov 6. PMID: 34741573; PMCID: PMC9298335.

4. Mesenchymal Stem Cell Secretome for Dermatology Application: A Review;Damayanti RH;Clin Cosmet Investig Dermatol,2021

5. White SE. Basic and clinical biostatistics. 5th ed. ed. New York: McGraw Hill; 2020. pp. 117–9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3